COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
Biotechnology verified Verified Outcome TRL 9

Industrialized AI Drug Discovery

domain Client: A clinical-stage biotechnology company handshake Provider: NVIDIA / BioNeMo schedule Deploy: 2023
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Construction of one of the world's most powerful biological supercomputers to industrialize the mapping of biology using AI.

rate_review Analyst Verdict

"High Risk / High Reward. Recursion is redefining the industry standard by treating biology as a data problem. The scale of their dataset (23 petabytes) creates a massive moat."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Traditional drug discovery relies on reductionist hypotheses and manual experimentation, which is slow and high-failure. The complexity of biology exceeds human intuition.

psychology The Solution

Built the 'BioHive-1' supercomputer using NVIDIA DGX. Ingests millions of weekly cellular images to train foundation models (Phenom) that predict how chemical compounds interact with human cells.

settings_suggest Technical & Deployment Specs

Integrations
Automated Wet Lab
Deployment Model
On-Prem Supercomputer
Data Classification
IP / Image Data
Estimated TCO / ROI
Very High
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Clinical Translation High Clinical trials underway

trending_up Impact Trajectory

Audited value realization curve

Generated >23 petabytes of proprietary biological data Verified Outcome
Primary KPIConducted millions of automated experiments per week
Audit CycleAccelerated pipeline to multiple clinical stage assets

policy Compliance & Gov

  • Standards: Internal R&D
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: IP / Image Data

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock

Related Intelligence

article
Engineering & Core Modernization Partnership
View Outcome →
article
Equity-Based Student Financing (ISA)
View Outcome →
article
AI Performance Guarantee Insurance
View Outcome →
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A clinical-stage biotechnology company without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-535
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-535

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.